About Us       Blog       Clients       Disclaimer       Market Basics       Partners       Quotes & News       Video       Contact Us
The QualityStocks Daily Newsletter for Tuesday, June 3rd, 2014

The QualityStocks
Daily Stock List

graphic
graphic

Strategic Environmental & Energy Resources, Inc. (SENR)

We are highlighting Strategic Environmental & Energy Resources, Inc. (SENR) today, here at the QualityStocks Daily Newsletter.

Headquartered in Colorado, Strategic Environmental & Energy Resources, Inc. (SEER) is a foremost provider of patented and proprietary technologies and services to the renewable fuels, waste management, and oil and gas industries. The Company has three wholly-owned operating subsidiaries. These are REGS, LLC (Resource Environmental Group Services), Tactical Cleaning Company, LLC, and MV Technologies, LLC. SEER also has a majority-owned subsidiary, Paragon Waste Solutions, LLC.  SEER has started an aggressive manufacturing program. It has multiple units undergoing construction to fulfill current and anticipated demand in several vertical markets.  

The REGS subsidiary provides industrial and environmental services to the petroleum industry, different industrial and manufacturing clients, medical facilities, universities, government entities, and environmental and consulting firms in the Western U.S.  SEER’s Tactical Cleaning is a premier provider of service solutions to owners and operators of railcars, tanker trucks, frac tanks, as well as vac boxes. 

SEER’s MV Technologies solves H2S (Hydrogen Sulfide) challenges. MV Technologies has been supplying its H2SPlus™ systems to a broad array of industries for more than 10 years. SEER’s Paragon Waste Solutions affiliate is a developer of patent-pending waste destruction technology.

Last month, SEER announced its MV Technologies (MV) subsidiary was awarded an additional patent giving considerably expanded coverage for its innovative V3RU™ (vapor recovery) technology. The design of this technology is to minimize methane and other greenhouse gas emissions from oil and gas field operations. The initial patent was issued in June of 2012.

Yesterday, SEER announced that its subsidiary, MV Technologies, was awarded a contract to supply one of its H2SPlus™ systems for removal of hydrogen sulfide (H2S) at the Pixley Biogas anaerobic digestion facility in California. This past March, Pixley Biogas was awarded a $4.6 million grant by the California Energy Commission (CEC) for the digester, which will be built next to the existing Calgren Renewable Fuels Biorefinery. The biogas generated by the digester will be used to reduce natural gas consumption at the ethanol production facility. Consistent, cost-effective removal of H2S from the biogas stream is required for the project’s success.

Strategic Environmental & Energy Resources, Inc. (SENR), closed Tuesday's trading session at $1.54, up 11.59%, on 48,340 volume with 53 trades. The average volume for the last 60 days is 66,612 and the stock's 52-week low/high is $0.69/$1.72.

Grandparents.com, Inc. (GPCM)

Today we are reporting on Grandparents.com, Inc. (GPCM), here at the QualityStocks Daily Newsletter.

Trading on the OTC Markets’ OTCQB, Grandparents.com, Inc. owns and operates the grandparents.com website. The Company mainly serves the approximately 70 million grandparents in the United States. However, its audience also includes "boomers" and seniors who are not grandparents. The Company’s website offers advice on health and wellbeing, relationships and finances. It also offers advice on recipes, travel tips and recommended activities for grandparents, boomers and seniors. Grandparents.com is based in New York, New York.

Furthermore, Grandparents.com has established the American Grandparents Association (AGA). This is a membership association, which works to unite grandparents, boomers, as well as seniors around the concept that the age 50-plus demographic faces issues that are unique to them. Members of the AGA enjoy particular benefits. These include access to Grand Deals and other products and services provided by third parties that Grandparents.com endorses or recommends. As of May 15, 2014, there were close to 2 million members in the AGA.

To date, the Company has generated revenue principally from advertising. It continues to concentrate on creating more revenue streams from other sources. These include Grand Deals, endorsement opportunities, as well as the Grand Card. Grand Deals makes available to AGA members’ giveaways, discounts and other benefits on an assortment of products and services provided by the Company’s marketing partners. These relate to travel, entertainment, food and dining, wellness and online shopping. Marketing partners are asked to provide deals on their products or services, which are better than they otherwise provide to non-AGA members.

In addition, Grandparents.com plans to offer a paid-membership tier of the AGA. Other than from advertising, the Company expects to start generating additional revenue from at least one of these sources this year. Historically, it has generated largely all of its revenue via the sale of advertisements on its website. It expects that advertising will be a substantial revenue source for the Company as it continues to look for additional revenue sources.

Grandparents.com, Inc. (GPCM), closed Tuesday's trading session at $0.29, down 1.69%, on 458,300 volume with 22 trades. The average volume for the last 60 days is 89,904 and the stock's 52-week low/high is $0.07/$0.44.

Micro Imaging Technology, Inc. (MMTC)

UltimatePennyStock, Vantage Wire, OTCPicks, Penny Stock Rumble, Stockpalooza, PennyTrader Publisher and Pennybuster reported previously on Micro Imaging Technology, Inc. (MMTC), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

Micro Imaging Technology, Inc. (MIT) has developed and patented the MIT 1000, a stand-alone, rapid, optically-based, software driven system. The MIT 1000 System is a bacterial cell based identification system. It can identify pathogenic bacteria in three minutes (average) at considerable cost savings per test. MIT is also registered to do business under the name Micro Identification Technologies. MIT lists on the OTC Markets’ OTCQB. The Company has its corporate head office in San Clemente, California.

The MIT 1000 System does not rely on chemical or biological agents, conventional processing, fluorescent tags, gas chromatography or DNA analysis. The process requires only clean filtered water and a sample of the unknown bacteria.

The MIT 1000 System has many applications. These include food safety, water quality control, clinical diagnostics, pharmaceutical and semiconductor process monitoring. The Company has selected to center firstly on food safety and clinical diagnostics. Its new laser light scattering technology has the potential to significantly simplify pathogen testing as well as reducing test time and cost. The Company believes that this will be a benefit to food manufacturers and consumers. The MIT 1000 System uses the principles of light scattering to discriminate different bacteria cells that are suspended in filtered water. 

In June 2009, the AOAC Research Institute (AOAC RI) awarded MIT Performance Tested Methods SM (PTM) certification for the rapid identification of Listeria. The AOAC RI provides an independent third party evaluation and expert reviews of methods. The AOAC RI will award PTM certification to methods that demonstrate performance levels equivalent or better than other certified bacteria identifying methods. The MIT System underwent hundreds of individual tests, including ruggedness and accuracy, to earn AOAC RI's certification for the identification of Listeria.

This past March, MIT announced that it delivered an MIT 1000 System as part of the Company’s collaboration with Northern Michigan University (NMU) to identify and differentiate Staphylococcus aureus (S. aureus) and Methicillin Resistant Staphylococcus aureus (MRSA). The goal of the collaboration is to swiftly and cost-effectively identify these two particular healthcare threats using the MIT 1000 System.

Micro Imaging Technology, Inc. (MMTC), closed Tuesday's trading session at $0.053, up even for the day, on 183,900 volume with 10 trades. The average volume for the last 60 days is 28,909 and the stock's 52-week low/high is $0.04/$1.00.

Nephros, Inc. (NEPH)

TopPennyStockMovers, Greenbackers, and SmarTrend Newsletters reported on Nephros, Inc. (NEPH), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Listed on the OTC Bulletin Board, Nephros, Inc. is a commercial stage medical device company. Founded in 1997, it develops and sells high performance liquid purification filters. Its “ultrafilters” are chiefly used in dialysis centers for the removal of biological contaminants from water, bicarbonate concentrate, and/or blood. Nephros has its headquarters in River Edge, New Jersey.

Healthcare professionals affiliated with Columbia University Medical Center/New York-Presbyterian Hospital founded Nephros to develop and commercialize an alternative method to hemodialysis (HD). The Company has extended its filtration technologies to meet the demand for liquid purification in other areas, in particular water purification.

Nephros filters use a proprietary hollow fiber technology. The hollow fiber design enables the filters to optimize filtration – as low as 5 nanometers; flow rate – minimal disruption; as well as filter life – up to 12 months. The Company has more than 100 patents issued globally based on 15 different inventions. These are mainly geared around its expertise as a filter development company, specializing in hollow fiber ultrafiltration membrane technology. Nephros offers ultrafilters for sale to customers in the Dialysis Centers - Water/Bicarbonate; Dialysis Centers – Blood; Military and Outdoor Recreation, and Commercial Facilities including Hospitals markets.

For Q1 2014, Nephros’ highlights include beginning shipment of its NanoGuard-D and NanoGuard-S ultrafilters. The Company also extended and expanded the Bellco S.r.l. license agreement for the MD220 dialyzer. It also signed a distribution agreement with Mar Cor for the DSU and SSU ultrafilters.

In addition, Nephros completed a $2.1 million Rights Offering. Furthermore, it completed the first commercial placement of the Nephros on-line mid-dilution Hemodiafiltration system and treatment of first patient.

Recently, Nephros announced the appointment of Matthew S. Rosenberg, M.D., to its Board of Directors. Dr. Rosenberg is an accomplished professional with broad healthcare public policy experience.  He was previously at McKinsey & Company, a global management consulting firm. While there, he focused on the Healthcare Systems and Services Practice.

Nephros, Inc. (NEPH), closed Tuesday's trading session at $1.17, up 0.86%, on 37,549 volume with 41 trades. The average volume for the last 60 days is 16,845 and the stock's 52-week low/high is $0.30/$1.71.

TX Holdings, Inc. (TXHG)

PennyStocks24, SecretStockPromo, StockOnion, Buzz Stocks, PennyStockProphet, Penny Pick Finders, and Planet Penny Stocks reported earlier on TX Holdings, Inc. (TXHG), and we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Incorporated in 2000, TX Holdings, Inc. is a supplier of mining and rail products to the U.S. coal mining industry. It is now focused exclusively on Rail, Rail Products, and Mining Supplies. The Company has partnered with a number of vendors with arrangements, with which TX Holdings expects to gain a larger presence in the marketplace. Furthermore, TX Holdings is currently expanding its customer base. The Company was previously known as R Wireless, Inc.  It changed its name to TX Holdings, Inc. in July of 2005. The Company has its corporate headquarters in Ashland, Kentucky.

TX Holdings has leased four acres situated in Ashland, Kentucky with a 5,000 square foot building to store the materials and equipment for the mining industry. Regarding Rail Products it offers tee rails that are used in railroad tracks for the transportation of coal by coal mine operators; steel ties for use in securing rail; switches; and related accessories and tools. Concerning Mining Supplies TX offers block and sleeves, miner parts, miscellaneous parts, bit bodies, drill steel, miner bits, roof bit bodies, roof bit assemblies, as well as carbide.

The Company sells its products directly to resellers. It also sells by way of independent sales agents to coal mine operators mainly in Ohio, Pennsylvania, Kentucky, and West Virginia.

In April, TX Holdings reported Second Quarter results for the 2014 Fiscal Year. Revenue for the quarter ended March 31, 2014, increased 26.5 percent in comparison to the quarter ended March 31, 2013. Its income from operations increased 25.8 percent in comparison to the quarter ended March 31, 2013. The Company’s net income increased 107 percent in comparison to the quarter ended March 31, 2013.

Mr. William Shrewsbury, TX Holdings’ Chief Executive Officer and Chairman, stated that "We are pleased with our quarterly results, especially since this is the fifth consecutive quarter in which we have reported net income. Our earnings grew during the second quarter of fiscal 2014 compared to 2013. We continue to focus on expanding our customer base and product offerings and controlling our product costs and operating expenses.” 

TX Holdings, Inc. (TXHG), closed Tuesday's trading session at $0.09, even for the day. The average volume for the last 60 days is 33,299 and the stock's 52-week low/high is $0.041/$0.14.

graphic

The QualityStocks
Company Corner

graphic
graphic

Raptor Resources Holdings Inc. (RRHI)

The QualityStocks Daily Newsletter would like to spotlight Raptor Resources Holdings Inc. (RRHI). Today, Raptor Resources Holdings Inc. closed trading at $0.0148, up 20.33%, on 221,000 volume with 7 trades. The stock’s average daily volume over the past 60 days is 48,171, and its 52-week low/high is $0.0051/$0.039.

Raptor Resources Holdings Inc. (RRHI) is a publicly traded holdings company focused on mineral resource acquisition, exploration, and development. The company currently has two subsidiaries: Mabwe Minerals Inc. (MBMI), a natural resources and hard asset company engaged in the mining and commercial sales of industrial minerals & metals with first focus on barite; and TAG Minerals Inc., a mineral & metal resource acquisition, exploration, and development company with first focus on alluvial surface gold.

Mabwe Minerals has been the focus of the parent company’s efforts the last two years to move into commercial barite production. RRHI shareholders share a common interest with MBMI shareholders in the success of Dodge Mine as the parent company owns 90M shares of MBMI. The Dodge Mine property consists of three hydrothermal mountains representing 123 hectares containing multiple deposits of superior-grade barite, limestone, and talc.

TAG Minerals, along with its indigenous affiliate, TAG Minerals Zimbabwe (Private) Limited, is responsible for alluvial gold production along with the development of greenfield assets targeting bedrock gold and other potential metals & minerals. As MBMI is transitioning into commercial barite production, RRHI will now focus on building assets within TAG Minerals with the intent of moving into commercial production within the next 18 months. TAG Minerals will utilize the latest in Heavy Particle Concentrators (HPC-30/HPC-100) through its relationship with Extrac-TEC whose gold recovery and mineral separation technology captures up to 98% of alluvial gold down to 50 microns. The company is in early stage exploration evaluating potential alluvial sites to ensure they meet the company's criteria for commercial production. Coupled with MBMI's acquisition of WGB Kinsey & Company, TAG Minerals is well positioned to fast track into commercial production once the company has successfully completed its exploratory testing.

RRHI management continues to improve its balance sheet as reflected in the company's SEC 10k filing, including favorable reductions in the company's debt/liabilities and securing 54.4M shares and 14.4M warrants of RRHI from prior employees. The company is committed to growing its asset base in TAG Minerals moving forward. Disclaimer

Raptor Resources Holdings Inc. Company Blog

Raptor Resources Holdings Inc. News:

Raptor Resources Holdings Issues Update on the Derbyshire Stone Quarry

Raptor Resources Holdings Acquires the Derbyshire Stone Quarry

Raptor Resources Holdings Completes Expansion of the Dodge Mine Mountain Range

VistaGen Therapeutics, Inc. (VSTA)

The QualityStocks Daily Newsletter would like to spotlight VistaGen Therapeutics, Inc. (VSTA). Today, VistaGen Therapeutics, Inc. closed trading at $0.63, up 26.00%, on 1,389 volume with 1 trade. The stock’s average daily volume over the past 60 days is 4,543, and its 52-week low/high is $0.25/$0.89.

VistaGen Therapeutics, Inc. (VSTA) is a biotechnology company applying stem cell technology for drug rescue and cell therapy. Drug rescue combines human stem cell technology with modern medicinal chemistry to generate new chemical variants ("drug rescue variants") of once-promising drug candidates that have been discontinued during late-stage preclinical development due to heart or liver safety concerns. VistaGen also focuses on cell therapy, or regenerative medicine, which includes repairing, replacing or restoring damaged tissues or organs.

VistaGen's versatile stem cell technology platform, Human Clinical Trials in a Test Tube™, has been developed to provide clinically relevant predictions of potential heart and liver toxicity of promising new drug candidates long before they are ever tested on humans.

By more closely approximating human biology than conventional animal studies and other nonclinical techniques and technologies currently used in drug development, VistaGen's human stem cell-based bioassay systems can improve the predictability of the drug development cycle and lower the cost of new drug research and development by identifying product failures earlier in the cost curve.  According to the Food and Drug Administration even only a ten percent improvement in predicting failure before clinical trials could save $100 million in development costs, which savings ultimately could be passed on to patients.

Using mature human heart cells produced from stem cells, VistaGen has developed and internally validated CardioSafe 3D™, a novel three-dimensional (3D) bioassay system for predicting the in vivo cardiac effects of new drug candidates before they are tested in humans. VistaGen is now focused on using CardioSafe 3D™ to generate up to two new, safer small molecule drug rescue variants every twelve to eighteen months.  VistaGen anticipates that these drug rescue variants will be modified versions of once-promising new drug candidates that have been discontinued by pharmaceutical companies and academic research institutions because of heart toxicity concerns, despite substantial prior investment and positive efficacy data demonstrating their potential therapeutic and commercial benefits.  In most cases, VistaGen plans to license or sell its new, safer drug rescue variants in strategic partnering arrangements with global pharmaceutical companies, arrangements providing VistaGen with both near term and downstream milestone payments and economic participation rights but without future development cost obligations. 

AV-101, VistaGen's lead small molecule prodrug candidate has successfully completed Phase I clinical development in the U.S. for treatment of neuropathic pain, a serious and chronic condition affecting millions of people worldwide, depression, and other neurological diseases and conditions. To date, the U.S. National Institutes of Health (NIH) has awarded VistaGen over $8.75 million for development of AV-101. Management anticipates strategically out-licensing AV-101 to a development and marketing partner in 2013.

Neuropathic pain affects approximately 1.8 million people in the U.S. alone. Although the current active AV-101 IND is for the treatment of neuropathic pain, VistaGen's development plan and regulatory strategy for AV-101 has been designed to allow its Phase 1 safety studies to support Phase 2 development for depression, epilepsy, Huntington's Disease and Parkinson's disease, indications for which there is now supporting preclinical efficacy data.  To date, VistaGen has been awarded over $8.5 million from the U.S. National Institutes of Health (NIH) for development of AV-101.

VistaGen is also developing LiverSafe 3D™, a novel predictive liver toxicity and drug metabolism bioassay system for drug rescue applications. In parallel with drug rescue activities, the Company is funding early-stage nonclinical studies focused on potential cell therapy applications of its Human Clinical Trials in a Test Tube™ platform. Disclaimer

VistaGen Therapeutics, Inc. Company Blog

VistaGen Therapeutics, Inc. News:

VistaGen Joins HESI's Cardiac Safety Committee and Working Groups

VistaGen Receives Notice of Allowance for U.S. Patent Expanding Stem Cell Technology Platform for Drug Rescue and Regenerative Medicine

VistaGen Joins the Cardiac Safety Research Consortium

International Stem Cell Corp. (ISCO)

The QualityStocks Daily Newsletter would like to spotlight International Stem Cell Corp. (ISCO). Today, International Stem Cell Corp. closed trading at $0.154, up 2.67%, on 372,617 volume with 54 trades. The stock’s average daily volume over the past 60 days is 471,563, and its 52-week low/high is $0.13/$0.299.

International Stem Cell Corp. (ISCO) specializes in the therapeutic applications of human parthenogenetic stem cells (hpSCs) and the development and commercialization of cell-based research and cosmetic products. The company was first to perfect the natural phenomenon of parthenogenesis, which utilizes unfertilized human eggs to create hpSCs. These stem cells, created in a particular form called HLA homozygous, can be immune-matched to millions of people regardless of sex or racial background, with minimal expectation of immune rejection after transplantation.

hpSCs are as pluripotent as embryonic stem cells (ESCs) and have significant therapeutic potential but their creation does not involve the destruction of a viable human embryo – thus sidestepping the controversy and ethical dilemmas associated with the use of human embryonic stem cells. Different from induced pluripotent stem cells (iPSs), hpSCs do not involve manipulation of gene expression back to a less differentiated stage – a practice that may become a safety or regulatory obstacle in clinical applications.

A relatively small number of hpSC lines can offer the potential of producing the first true stem cell bank, UniStemCell, which ISCO intends to create as a means of serving populations across the globe. The company's scientists are currently focused on using hpSC to treat severe diseases of the eye, nervous system, and liver, for which cell therapy has been clinically proven but is limited due to the unavailability of safe human cells.

In addition to its therapeutic focus, ISCO also provides two revenue streams. Firstly through its subsidiary Lifeline Cell Technology, specialized cells and growth media for biological research around the world, and secondly its subsidiary Lifeline Skin Care, the company manufactures and sells anti-aging skincare products utilizing an extract from the hpSC and by leveraging the latest discoveries in the fields of stem cell biology, nanotechnology, and skin cream formulation technology. Disclaimer

International Stem Cell Corp. Company Blog

International Stem Cell Corp. News:

International Stem Cell Corporation Announces Positive R&D and Business Results for First Quarter 2014

International Stem Cell Corporation to Host First Quarter 2014 Business Update and Financial Results Conference Call at 11:00 am ET on Wednesday, May 14, 2014

International Stem Cell Corporation Announces Positive Parkinson's Disease Data

Ecrypt Technologies, Inc. (ECRY)

The QualityStocks Daily Newsletter would like to spotlight Ecrypt Technologies, Inc. (ECRY). Today, Ecrypt Technologies, Inc. closed trading at $0.121, up 0.83%, on 10,000 volume with 2 trades. The stock’s average daily volume over the past 60 days is 7,068 and its 52-week low/high is $0.055/$0.28.

Ecrypt Technologies, Inc. (ECRY) is an emerging provider of military-strength data security solutions for enterprise, government, and military. The company empowers organizations with the freedom to communicate and collaborate without risk of liability, reputation damage, competitive threat, and other negative outcomes. Ecrypt is the trusted first choice for those looking to keep their communications confidential.

Today’s businesses struggle to guard against the increasing number of dangers as a result of complicated networks built with many different components that are often individually patched to address new threats, while neglecting to close security gaps in traditional solutions. On average, data breaches and subsequent fines and litigation cost a US business $534 million every year, the highest in the world according to the Ponemon Institute.

The flagship Ecrypt solution is an integrated email and encryption server that can be quickly deployed to fortify the security of corporate communication, including attachments and mobile devices, against data breaches while eliminating phishing threats, malware infections, and spam. By using Ecrypt’s paradigm-shifting technology, companies alleviate the need for separate encryption servers with their associated bloated administration and multiple points of weakness.

Ecrypt is well positioned to benefit from increasingly demanding data confidentiality regulations such as the Health Insurance Portability and Accountability Act (HIPAA), the Federal Information Security Management Act (FISMA), and Gramm-Leach-Bliley Act (GLBA). As a result of extensive market research and working directly with organizations in multi-billion dollar industries, the company fully understands the business community’s need to maintain confidentiality, prevent data breaches, comply with government regulations, and mitigate litigation risks. Disclaimer

Ecrypt Technologies, Inc. Blog

Ecrypt Technologies, Inc. News:

Ecrypt Technologies Appoints Former Microsoft Engineer to Advisory Board

Ecrypt Technologies Forms Advisory Board

Ecrypt Technologies, Inc. Commences Development of a Product Sandbox

Infinite Group, Inc. (IMCI)

The QualityStocks Daily Newsletter would like to spotlight Infinite Group, Inc. (IMCI). Today, Infinite Group, Inc. closed trading at $0.0749, even for the day, on 27,075 volume with 4 trades. The stock’s average daily volume over the past 60 days is 7,401, and its 52-week low/high is $0.05/$0.20.

Infinite Group, Inc. (IMCI) professionals plan, integrate, manage and support complete IT solutions for customers in small to medium-sized businesses, government agencies and large commercial enterprises. Dedicated to quality and customer service, the company’s team of over 80 IT specialists is experienced in their individual fields and maintains the latest certifications. Infinite Group also partners with industry leaders such as VMware, HP, Microsoft, Cisco, and Dell to ensure its customers receive the best combination of products and services designed for their specific needs.

The company’s scalable solutions cover the entire IT chain, including consulting and project management, data storage and recovery solutions, IT security, managed services, and complete IT system development. Providing customers a single point of contact for all their IT needs, Infinite Group helps companies focus on their core business by improving IT efficiencies, reducing capital expenditures, and enjoying significant savings on operational costs.

Based in the Rochester, New York area, the company leverages its deep roots in technology to be one of today’s premier IT service and support suppliers. The company’s IT professionals provide on-site support to customers around the world and serve some of the premiere businesses and government organizations in the United States and worldwide including the U.S. Post Office, PepsiCo, Inc., the State of Mississippi, Home Depot, NASA, Pricewaterhouse Coopers, the Florida Department of Financial Services, the U.S. Air Force, Navy, Army, and others. Personnel are located throughout the U.S. including Colorado Springs, Springfield and Vienna, Virginia and Washington, D.C. for added government support.

The IT services industry generates $500 billion in annual revenues and continues to grow as businesses progressively rely on technology to maintain operations and increase efficiency. With decades of experience and technical knowledge, and guided by the highest governance and business conduct guidelines, Infinite Group’s leadership team meets current and future business demands with expertise and effectiveness. Disclaimer

Infinite Group, Inc.Company Blog

Infinite Group, Inc.News:

Infinite Group, Inc. Partners With Unitrends to Provide Data Protection

Cybersecurity on Infinite Group, Inc.'s Radar With New Hire

Infinite Group, Inc. CEO Featured in Exclusive QualityStocks Interview

graphic

Rate Us
Tell us how we're doing!
Click here to begin your review.

Today's Top 3
Investment Newsletters

graphic

1.

StockBomb.com
(BFLX)

2.

TheMicrocapNews
(CJTF)

3.

Dividend Opportunities
(GHIL)

graphic
By The Numbers Charts
QualitystockTwits

The QualityStocks Public Company Sponsor News

Featured Sponsor

Daily Sponsors
















 

The QualityStocks By The Numbers Report

Click the chart below to see the full report

About "The QualityStocks Daily"

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market
each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge"
based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?

We Want To bring our subscribers the top movers in an unbiased setting.

“Homework Eliminates Mistakes"

Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.

 

About Us     Archives     Blog     Clients     Disclaimer     Market Basics    Partners      Quotes & News     Video     Contact Us

twitter icon facebook icon

QualityStocks Logo

Copyright © 2006 - 2012. QualityStocks 3370 N. Hayden Rd., Suite 123-591, Scottsdale, AZ 85251